Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

280.84 +6.85 (+2.50%)

Official Closing Price Updated: 7:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Why the dividend investor may take a look at NYSE:WST. ↗

April 12, 2024

Via Chartmill

(WST) - Analyzing West Pharmaceutical Servs's Short Interest ↗

March 26, 2024

Via Benzinga

Exploring NYSE:WST's dividend characteristics. ↗

March 22, 2024

Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) is a Top Pick for Dividend Investors.

Via Chartmill

3 Pharma Stocks to Sell in March Before They Crash & Burn ↗

March 14, 2024

Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.

Via InvestorPlace

Analyzing NYSE:WST's Dividend Potential. ↗

March 01, 2024

Is WEST PHARMACEUTICAL SERVICES (NYSE:WST) a Good Fit for Dividend Investing?

Via Chartmill

S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday? ↗

February 15, 2024

US stocks surge on strong earnings and speculation of Fed rate cuts. S&P 500 rebounds past 5000, Nasdaq 100 pauses. Small caps outperform. Tesla, Wells Fargo, and CBRE rally on positive news while Deer...

Via Benzinga

Topics Economy Stocks

(WST) - Analyzing West Pharmaceutical Servs's Short Interest ↗

February 15, 2024

Via Benzinga

Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 15, 2024

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

Via Benzinga

West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic ↗

February 15, 2024

West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million missing estimates. 2024 guidance hints at moderated organic growth,...

Via Benzinga

West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75 ↗

February 15, 2024

WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.

Via Talk Markets

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a quality stock. ↗

February 09, 2024

Why the quality investor may take a look at WEST PHARMACEUTICAL SERVICES (NYSE:WST).

Via Chartmill

$1000 Invested In This Stock 15 Years Ago Would Be Worth $20,000 Today ↗

January 08, 2024

Via Benzinga

Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here's What You Need To Know ↗

February 13, 2024

Via Benzinga

TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades' ↗

February 08, 2024

On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated (NYSE: TDG), which is scheduled to release

Via Benzinga

Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 10 Years ↗

February 01, 2024

Via Benzinga

West Pharmaceutical Services Bullish Daily Cycle ↗

December 26, 2023

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems.

Via Talk Markets

Here's How Much $100 Invested In West Pharmaceutical Servs 15 Years Ago Would Be Worth Today ↗

December 25, 2023

Via Benzinga

How Is The Market Feeling About West Pharmaceutical Servs? ↗

December 20, 2023

Via Benzinga

How Is The Market Feeling About West Pharmaceutical Servs? ↗

November 30, 2023

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,300 Today ↗

November 20, 2023

Via Benzinga

Looking Into West Pharmaceutical Servs's Recent Short Interest ↗

November 13, 2023

Via Benzinga

Here's How Much $1000 Invested In West Pharmaceutical Servs 5 Years Ago Would Be Worth Today ↗

December 07, 2023

Via Benzinga

Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors ↗

November 14, 2023

These three oversold blue-chip stocks offer growth and long-term income while the stocks trade at attractive levels.

Via InvestorPlace

3 Dividend Champions with room for dividend growth

November 13, 2023

Dividend Champions that have payout ratios below 20%, like these three stocks, can be an incredibly compelling choice for buy-and-hold dividend investors.

Via MarketBeat

Sotera Health Appoints Karen Flynn to Board of Directors

November 13, 2023

From Sotera Health Services, LLC

Via GlobeNewswire

$100 Invested In West Pharmaceutical Servs 5 Years Ago Would Be Worth This Much Today ↗

November 09, 2023

Via Benzinga

Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 26, 2023

Gainers

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 25, 2023

Via Benzinga

Earnings Scheduled For October 26, 2023 ↗

October 26, 2023

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

All News about West Pharmaceutical Services, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today